Explore the Global Branded Generics Market— analysis of key trends, regional growth, top players, and a 10-year forecast from 2026 to 2036.

Future Market Insights

Branded Generics Market

Key Insight

Branded generics sales will expand through 2036, with oral formulations at 65.0% of formulation type demand in 2026. The market was valued at USD 382.4 billion in 2025 and is projected to reach USD 928.6 billion by 2036, creating an incremental opportunity of USD 514.1 billion between 2026 and 2036.

May 13, 2026

Anurag Sharma

342 Pages

Cite this Report

Branded Generics Market

https://www.futuremarketinsights.com/reports/branded-generics-market

License

Buy Now

Summary ToC Infographics Companies

Key Players

Abbott Laboratories
Aspen Pharmacare Holdings Limited
Eastman Chemical Company
GlaxoSmithKline Pharmaceuticals Ltd
Global Leaders
Novartis
The Vanguard Group
Specialty Portfolio Players
Sun Pharmaceutical
Berkshire Hathaway
Unifi
Viatris Inc
Zydus Lifesciences Ltd

Methodology

Member of

Greater New York Chamber of Commerce

Recognized by

Awarded by

SILVER STEVIE® WINNER

Asia Pacific Stevie Awards - 2023

BRONZE STEVIE® Award

20th annual IBAs

Quick Contact

Chat on Whatsapp + 44 20 3769 9709 + 1 347 918 3531 Contact By Email

Get Free Sample PDF

Branded Generics Market

Key Players

Similar Industry Reports